Trials / Withdrawn
WithdrawnNCT01129947
The Use of DHEA in Women With Premature Ovarian Failure
- Status
- Withdrawn
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Virginia Center for Reproductive Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
DHEA supplementation has been used in women with infertility and diminished ovarian reserve. There is a small report in 5 women with POF that benefited from the use of DHEA over several months. The investigators aim to evaluate further the use of DHEA in women with Premature ovarian failure (POF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DHEA | DHEA 25 mg tid |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2010-05-25
- Last updated
- 2013-01-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01129947. Inclusion in this directory is not an endorsement.